XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $56,000 | -39.1% | 22,478 | 0.0% | 0.00% | – |
| Q2 2021 | $92,000 | -83.3% | 22,478 | -81.6% | 0.00% | – |
| Q1 2021 | $550,000 | -5.2% | 121,937 | +3.4% | 0.00% | – |
| Q4 2020 | $580,000 | -9.1% | 117,873 | +9.7% | 0.00% | – |
| Q3 2020 | $638,000 | +158.3% | 107,496 | +16.2% | 0.00% | – |
| Q2 2020 | $247,000 | +43.6% | 92,546 | +5.0% | 0.00% | – |
| Q1 2020 | $172,000 | -63.9% | 88,114 | +30.4% | 0.00% | – |
| Q4 2019 | $477,000 | -28.3% | 67,583 | 0.0% | 0.00% | – |
| Q3 2019 | $665,000 | -14.1% | 67,583 | 0.0% | 0.00% | – |
| Q2 2019 | $774,000 | +43.6% | 67,583 | +26.0% | 0.00% | – |
| Q1 2019 | $539,000 | +118.2% | 53,627 | +270.1% | 0.00% | – |
| Q4 2018 | $247,000 | -3.1% | 14,491 | 0.0% | 0.00% | – |
| Q3 2018 | $255,000 | – | 14,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $14,901,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,553,398 | $26,672,000 | 0.47% |
| Alpine Global Management, LLC | 354,524 | $1,443,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 275,500 | $1,121,000 | 0.15% |
| Kamunting Street Capital Management, L.P. | 67,594 | $275,000 | 0.11% |
| IHT Wealth Management, LLC | 340,147 | $1,384,000 | 0.09% |
| Redmile Group, LLC | 1,358,825 | $5,530,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 173,318 | $705,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,815,091 | $7,387,000 | 0.06% |
| GPS Wealth Strategies Group, LLC | 49,025 | $200,000 | 0.05% |